领航医药生物科技(00399.HK)进一步延长配售最后截止日期

Core Viewpoint - The company has extended the deadline for the subscription agreement with Subscriber A from August 26, 2025, to September 16, 2025, or another date mutually agreed upon in writing by both parties [1] Group 1 - The company announced the need for additional time to fulfill the conditions precedent outlined in the subscription agreement [1] - A further extension letter has been signed with Subscriber A to formalize the new deadline [1]